Sanofi
SNY
₹4,347
Share price
0.67%
Change (1 day)
14.64%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
EPS for Sanofi (SNY)
EPS in 2023 (TTM): ₹262.63
According to Sanofi's latest financial reports the company's current EPS (TTM) is ₹271.62. In 2022 the company made an earnings per share (EPS) of ₹241.41 a decrease over its 2021 EPS that were of ₹246.06.
EPS history for Sanofi from 2003 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | ₹262.63 | 8.79% |
| 2022 | ₹241.41 | -1.89% |
| 2021 | ₹246.06 | |
| 2019 | ₹105.63 | -38.94% |
| 2018 | ₹172.99 | -45% |
| 2017 | ₹314.51 | 81.18% |
| 2016 | ₹173.59 | 11.11% |
| 2015 | ₹156.23 | -15.47% |
| 2014 | ₹184.83 | 15.44% |
| 2013 | ₹160.11 | -22.73% |
| 2012 | ₹207.22 | -16.93% |
| 2011 | ₹249.44 | 6.2% |
| 2010 | ₹234.88 | -2.75% |
| 2009 | ₹241.52 | 166.84% |
| 2008 | ₹90.51 | -61.18% |
| 2007 | ₹233.12 | 45.79% |
| 2006 | ₹159.90 | 28.81% |
| 2005 | ₹124.14 | -37.69% |
| 2004 | ₹199.21 | 32.29% |
| 2003 | ₹150.59 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | ₹155.59 | -42.72% | 🇺🇸 USA |
 | ₹158.86 | -41.51% | 🇺🇸 USA |
 | ₹339.07 | 24.83% | 🇺🇸 USA |
 | ₹319.43 | 17.60% | 🇨🇭 Switzerland |
 | ₹298.99 | 10.08% | 🇬🇧 UK |
 | -₹170.82 | -162.89% | 🇮🇱 Israel |
 | ₹1,203 | 342.90% | 🇺🇸 USA |
 | ₹463.71 | 70.72% | 🇺🇸 USA |
 | ₹243.91 | -10.20% | 🇩🇰 Denmark |
 | ₹253.85 | -6.54% | 🇺🇸 USA |